NN

Neeru Narula

Active Director Director DIN 03213756
DIN 03213756 First appointment Jul 1996 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 1996
Shareholding value Locked Premium profile

About Neeru Narula

Neeru Narula has 30 years in corporate governance. Holds Director role. Currently with 1 company, including Hahnemann Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03213756
Primary Designation Director
First Appointment 14 Jul 1996
Oldest Company Age 30 yrs

Current companies

Company Designation Appointment Founded Status
Director 14 Jul 1996 1996 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hahnemann Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neeru Narula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeru Narula

Neeru Narula has 30 years in corporate governance. Holds Director role. Currently with 1 company, including Hahnemann Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Neeru Narula is associated with 1 company as Director.

Neeru Narula has expertise in General Business.

Neeru Narula has 30 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available